May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Apoptosis-linked Gene-2 (ALG-2)- A Potential Site for Therapeutic Intervention in Retinal Degeneration and Uveal Melanoma
Author Affiliations & Notes
  • L. Subramanian
    Biomolecular Chemistry, University Wisconsin-Madison, Madison, WI, United States
  • P.R. van Ginkel
    Ophthalmology/Visual Sciences, University Wisconsin-Madison, Madison, WI, United States
  • T.M. Walker
    Ophthalmology/Visual Sciences, University Wisconsin-Madison, Madison, WI, United States
  • A.S. Polans
    Biomolecular Chemistry, Opthalmology/Visual Sciences, University Wisconsin-Madison, Madison, WI, United States
  • Footnotes
    Commercial Relationships  L. Subramanian, None; P.R. van Ginkel, None; T.M. Walker, None; A.S. Polans, None.
  • Footnotes
    Support  Support NIH EY 12768 and EY 13705, Research to Prevent Blindness, Inc. ASP is a Jules & Doris Stein
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2844. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Subramanian, P.R. van Ginkel, T.M. Walker, A.S. Polans; Apoptosis-linked Gene-2 (ALG-2)- A Potential Site for Therapeutic Intervention in Retinal Degeneration and Uveal Melanoma . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2844.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To characterize calcium-induced conformational changes leading to the interaction of ALG-2 with AIP1, a putative effector molecule. ALG-2 was identified as a pro-apoptotic calcium-binding protein. In the eye, ALG-2 is expressed predominantly in photoreceptor cells. ALG-2 could play a role in the calcium-mediated apoptosis associated with retinal degeneration. Further, ALG-2 is down-regulated in uveal melanoma cell lines endowing a selective advantage to these tumor cells. Methods: TNS fluorescence to study conformational changes, cross-linking and analytical centrifugation to study dimerization, covalent modification, site-directed mutagenesis and co-immunoprecipitation to study regions of interaction. Results: Cross-linking experiments demonstrate that ALG-2 is present as a dimer in both normal melanocytes and uveal melanoma cells independent of intracellular calcium concentration. This is consistent with in vitro cross-linking results using recombinant ALG-2. Analytical centrifugation in the absence of calcium shows that ALG-2 exists predominantly as a dimer. In the presence of calcium, ALG-2 forms aggregates. Deletion of the N-terminal region results in improved solubility of the protein but does not affect dimerization. TNS fluorescence studies show similar calcium-induced conformational changes with or without the N-terminal region. Covalent modification experiments to identify residues affected by the conformational change are in progress. The N-terminal region, which appears to be involved in the calcium-induced aggregation of ALG-2 could potentially be important for target recognition and interaction. Co-immunoprecipitation experiments combined with site-directed mutagenesis will help delineate the mechanism of interaction at the molecular level. Conclusions: ALG-2 could potentially be involved in two major blinding diseases: retinal degeneration by mediating aberrant levels of calcium and uveal melanoma by down-regulation. Understanding the mechanisms of calcium-induced ALG-2 activation could lead to opportunities for therapeutic intervention.

Keywords: cell death/apoptosis • retinal degenerations: cell biology • melanoma 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×